Marc Miravitlles Selected Research

Bronchodilator Agents (Bronchodilators)

3/2022	Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
1/2022	Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain.
1/2022	Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.
7/2020	Tiotropium in chronic obstructive pulmonary disease - a review of clinical development.
1/2020	Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline.
9/2019	Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care.
9/2018	What have we learned from observational studies and clinical trials of mild to moderate COPD?
7/2018	Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?
4/2018	Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
1/2018	The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Miravitlles Research Topics

Disease

182	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 09/2002
26	Asthma (Bronchial Asthma) 10/2022 - 09/2012
17	Emphysema 10/2022 - 02/2008
17	Dyspnea (Shortness of Breath) 04/2022 - 04/2006
16	Chronic Bronchitis 01/2020 - 02/2005
12	Pneumonia (Pneumonitis) 02/2022 - 02/2005
11	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022 - 02/2005
10	Infections 10/2021 - 12/2005
8	Inflammation (Inflammations) 07/2021 - 01/2015
7	Bronchiectasis 01/2022 - 01/2005
7	Lung Diseases (Lung Disease) 01/2022 - 06/2012
5	Liver Diseases (Liver Disease) 11/2021 - 01/2020
5	Eosinophilia 04/2018 - 09/2012
4	Bronchitis 02/2022 - 06/2011
4	Cough 10/2021 - 12/2007
3	Rhinosinusitis 02/2022 - 02/2005
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
3	Disease Progression 03/2021 - 01/2017
3	Airway Obstruction (Choking) 04/2018 - 12/2006
3	Bacterial Infections (Bacterial Infection) 06/2017 - 11/2013
2	Respiratory Insufficiency (Respiratory Failure) 04/2022 - 01/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2021 - 01/2021
2	Obstructive Lung Diseases (Obstructive Lung Disease) 07/2018 - 06/2013
2	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 10/2016 - 12/2014
2	Respiratory Sounds (Crackle) 01/2015 - 06/2012
1	Malnutrition (Nutritional Deficiencies) 04/2022
1	Hypoxia (Hypoxemia) 04/2022
1	Pharyngitis (Sore Throat) 02/2022
1	Human Influenza (Influenza) 02/2022
1	Respiratory Acidosis 02/2022
1	Cholelithiasis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Fatigue 10/2021
1	Long Term Adverse Effects 06/2021

Drug/Important Bio-Agent (IBA)

48	Bronchodilator Agents (Bronchodilators)IBA 03/2022 - 12/2006
39	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 04/2006
36	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 03/2004
34	GoldIBA 01/2021 - 04/2006
18	Biomarkers (Surrogate Marker)IBA 04/2022 - 05/2010
13	Tiotropium Bromide (Spiriva)FDA Link 01/2021 - 06/2007
12	Moxifloxacin (Avelox)FDA Link 01/2015 - 01/2003
11	Muscarinic AntagonistsIBA 10/2022 - 01/2015
8	Pharmaceutical PreparationsIBA 01/2021 - 12/2005
7	C-Reactive ProteinIBA 02/2022 - 12/2010
6	Amoxicillin (Wymox)FDA LinkGeneric 01/2019 - 01/2009
5	SmokeIBA 10/2021 - 06/2006
5	Formoterol Fumarate (Oxis)FDA Link 10/2018 - 10/2009
4	tiotropium-olodaterolIBA 01/2021 - 10/2016
4	MacrolidesIBA 01/2019 - 01/2007
4	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2013 - 01/2009
3	Oxygen (Dioxygen)IBA 04/2022 - 08/2012
3	Biological ProductsIBA 04/2022 - 05/2020
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 06/2012
3	Penicillins (Penicillin)FDA Link 01/2019 - 12/2005
3	Penicillin V (Phenoxymethylpenicillin)FDA LinkGeneric 01/2019 - 12/2005
3	Budesonide (Pulmicort)FDA LinkGeneric 10/2018 - 10/2009
3	Fluticasone (Cutivate)FDA LinkGeneric 10/2018 - 01/2018
3	Salmeterol Xinafoate (Serevent)FDA Link 07/2018 - 06/2007
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2016 - 06/2005
3	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2013 - 01/2011
2	EnzymesIBA 01/2022 - 01/2021
2	PolymersIBA 11/2021 - 09/2021
2	3' Untranslated Regions (3' UTR)IBA 07/2021 - 05/2020
2	LipopolysaccharidesIBA 07/2021 - 05/2020
2	olodaterolIBA 01/2021 - 11/2017
2	Fibrinogen (Factor I)FDA Link 01/2020 - 05/2010
2	RoflumilastIBA 01/2019 - 10/2016
2	PeriostinIBA 04/2018 - 01/2018
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2018 - 01/2015
2	prednylidene (Pred)IBA 01/2018 - 01/2017
2	indacaterolIBA 01/2018 - 10/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 05/2010
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 10/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 05/2010
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2018 - 08/2013
2	Carbon MonoxideIBA 01/2017 - 08/2004
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 06/2012
2	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2017 - 09/2016
2	vilanterolIBA 01/2016 - 10/2015
2	GSK573719IBA 01/2016 - 10/2015
2	Immunologic Factors (Immunomodulators)IBA 05/2008 - 04/2005
2	Immunoferon (AM3)IBA 05/2008 - 04/2005
1	Losartan (Cozaar)FDA LinkGeneric 10/2022
1	Opioid Analgesics (Opioids)IBA 04/2022
1	EmbarcIBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 09/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2021
1	GasesIBA 01/2021

Therapy/Procedure

72	Therapeutics 10/2022 - 01/2007
10	Nebulizers and Vaporizers (Inhaler) 10/2022 - 10/2015
4	Artificial Respiration (Mechanical Ventilation) 02/2022 - 01/2012
4	Aftercare (After-Treatment) 09/2018 - 01/2003
2	Palliative Care (Palliative Therapy) 04/2022 - 01/2017
2	Lung Transplantation 01/2017 - 08/2015
2	Antibiotic Prophylaxis 06/2015 - 12/2013
2	Activities of Daily Living (ADL) 06/2012 - 02/2007
1	Intravenous Infusions 03/2021
1	Length of Stay 01/2021